2026 FDLI Annual Conference

The 2026 FDLI Annual Conference, organized by the Food and Drug Law Institute (FDLI), is the premier event for the food and drug law community. This conference offers a unique platform to explore complex legal, regulatory, compliance, and policy issues affecting FDA-regulated industries. Attendees will include experts from federal government agencies, industry, private law firms, patient and consumer advocacy groups, consulting organizations, and academia.

The conference will feature over 30 sessions covering the latest developments in legal, regulatory, compliance, policy, marketing, and related areas. Participants will have the opportunity to hear directly from FDA officials and other key leaders within federal agencies, including Health and Human Services. Additionally, the event will highlight the top cases in food and drug law, providing valuable insights into recent legal precedents and their implications.

Beyond the sessions, the conference offers numerous networking opportunities, allowing attendees to build relationships with seasoned professionals across legal, regulatory, compliance, policy, and government sectors. With more than 100 well-known officials and experts scheduled to speak, participants can expect a comprehensive and engaging experience.

This conference is ideal for legal professionals, regulatory affairs specialists, compliance officers, policymakers, industry executives, and academics involved in FDA-regulated sectors. Attending will provide valuable insights, facilitate professional growth, and offer opportunities to influence policy and practice within the food and drug law community.